E&G Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$239K Buy
+1,136
New +$228K 0.05% 225
2016
Q1
– Sell
-4,125
Closed -$465K – 98
2015
Q4
$465K Sell
4,125
-300
-7% -$32.6K 0.28% 66
2015
Q3
$447K Buy
4,425
+600
+16% +$72K 0.28% 67
2015
Q2
$470K Sell
3,825
-2,100
-35% -$251K 0.27% 69
2015
Q1
$678K Buy
5,925
+195
+3% +$21.5K 0.4% 62
2014
Q4
$579K Sell
5,730
-390
-6% -$37.9K 0.38% 64
2014
Q3
$558K Buy
+6,120
New +$537K 0.36% 73

Other funds holding IBB

E&G Advisors's IBB Position: Q3 2026 in Review

E&G Advisors opened a new position in iShares Biotechnology ETF (IBB) in Q3 2026: 1,136 shares worth $239K. The stake represents 0.05% of the portfolio and ranks #225 among its holdings. This is a return to the name: E&G Advisors previously reported a position in IBB as recently as Q4 2015.

E&G Advisors first reported a position in IBB in Q3 2014 and has held it in 7 quarters since. The position peaked at $678K in Q1 2015. 1,019 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • E&G Advisors held 1,136 shares of iShares Biotechnology ETF worth $239K as of Q3 2026.
  • iShares Biotechnology ETF was a new E&G Advisors position in Q3 2026.
  • iShares Biotechnology ETF made up 0.05% of E&G Advisors's portfolio in Q3 2026, its #225 holding.
  • E&G Advisors first reported a position in iShares Biotechnology ETF in Q3 2014 and has held it in 7 quarters since.
  • E&G Advisors's iShares Biotechnology ETF position peaked at $678K in Q1 2015.
  • 1,019 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on E&G Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.